Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emphysematous cystitis: imaging patterns and diagnostic approach on CT.

Emergency radiology·2026
Same author

From Bench to Bedside: The Path Toward Real-World Translation for Artificial Intelligence in Pancreatic Cancer Detection.

Korean journal of radiology·2026
Same author

Altered renal corticomedullary differentiation on CT, Part I: A pictorial review of non-neoplastic causes.

Emergency radiology·2026
Same author

Altered renal corticomedullary differentiation on CT, Part II: a pictorial review of malignant causes.

Emergency radiology·2026
Same author

A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Hyperplasia Functions as a Link between Obesity and Cancer.

Cancer research·2026
Same journal

Type II JAK2 Inhibitor Gets Off to a Strong Start.

Cancer discovery·2026
Same journal

Pancreatic Cancer: Translating Tumor Biology into Actionability.

Cancer discovery·2026
Same journal

Reconsidering Cancer Therapy through the Lens of Biomolecular Condensates.

Cancer discovery·2026
Same journal

The Promise of Machine Learning-Based Population Screening for Hepatocellular Carcinoma.

Cancer discovery·2026
Same journal

Spatially Resolved Proteomic Cartography Illuminates the Earliest Molecular Programs in Pancreatic Cancer Evolution.

Cancer discovery·2026
Same journal

Oral Regimens for AML Make Strides.

Cancer discovery·2026
See all related articles

Related Experiment Video

Updated: Sep 10, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

665

Translating Artificial Intelligence Breakthroughs into Cancer Diagnostic Breakthroughs.

Juan M Lavista Ferres1, Elliot K Fishman2, Ed Catmull3

  • 1AI For Good, MIcrosoft Research Lab, Redmond, California.

Cancer Discovery
|August 20, 2025
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) has great potential in oncology diagnostics but faces eight key challenges. Addressing these issues is crucial for integrating AI into clinical cancer care.

More Related Videos

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

236
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.9K

Related Experiment Videos

Last Updated: Sep 10, 2025

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

665
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

236
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.9K

Area of Science:

  • Oncology
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Artificial intelligence (AI) is transforming various fields, yet its clinical application in oncology remains limited.
  • Significant opportunities exist for AI to enhance cancer diagnostics and patient care.

Purpose of the Study:

  • To identify and elaborate on critical challenges hindering the clinical translation of AI in oncology diagnostics.
  • To provide a roadmap for overcoming these obstacles and facilitating AI adoption in cancer care.

Main Methods:

  • A focused review and expert discussion identifying key barriers to AI implementation in oncology.
  • Categorization of challenges specifically related to diagnostic applications of AI in cancer.

Main Results:

  • Eight principal challenges impeding AI integration into oncology diagnostics were identified.
  • These challenges span areas such as data quality, model validation, clinical workflow integration, and regulatory approval.

Conclusions:

  • Overcoming the identified challenges is essential for realizing the full potential of AI in oncology.
  • Addressing these diagnostic-focused hurdles will pave the way for widespread AI adoption in clinical cancer settings.